E3 Ubiquitin Ligase RNF126 Promotes Ovarian Cancer Progression and Cisplatin Resistance Through Targeting Numb/Notch1 Axis
Frontiers in Bioscience-Landmark · 2026
DOI: 10.31083/fbl54223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Tianjiao Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The First Affiliated Hospital of Harbin Medical University, 150001 Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cisplatin, Ubiquitin-Protein Ligases, Drug Resistance, Neoplasm. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fund of Scientific Research Innovation of the First Affiliated Hospital of Harbin Medical University, Project of the Health Commission of Heilongjiang Province.
Abstract (Originalsprache)
Background:RING finger protein 126 (RNF126) is an E3 ubiquitin ligase that is overexpressed in various malignancies. However, its role in ovarian cancer remains poorly understood.Methods:Ovarian cancer cell lines, including SKOV3, A2780, and cisplatin-resistant SKOV3/DDP, were utilized in this study. RNF126 expression was modulated via lentiviral transduction. Cell viability, colony formation, and migration were assessed by cell counting kit-8 (CCK-8), colony formation, and Transwell assays. Protein and mRNA levels were measured by Western blotting and real-time quantitative PCR (qPCR). Protein interaction was evaluated by co-immunoprecipitation and ubiquitination assays. In vivo tumor growth and cisplatin response were examined using a xenograft model.Results:In SKOV3 and A2780 cells, RNF126 overexpression promoted proliferation, colony formation, and migration, while its knockdown produced the opposite effects. Notably, elevated RNF126 expression was observed in the cisplatin-resistant SKOV3/DDP line. Silencing RNF126 in these cells increased cisplatin sensitivity while concurrently reducing proliferative capacity, clonogenicity, and migratory potential. RNF126 depletion in SKOV3/DDP cells led to decreased mRNA and protein expression of Notch1 and its downstream targets Myc, Cyclin D3, and Hes1. Meanwhile, Numb mRNA levels remained unchanged, whereas its protein levels increased, indicating post-transcriptional regulation. Furthermore, Numb silencing increased cell viability, clonality, migration, and Notch signaling activation in RNF126 knockdown SKOV3/DDP cells. In vivo, silencing RNF126 markedly enhanced the sensitivity of cells to cisplatin, suppressed tumor growth, and inhibited Myc, Cyclin D3, Hes1, and Notch1 protein expression. Silencing Numb can reverse the inhibitory effects of RNF126 knockdown. Mechanistic studies showed that RNF126 directly binds to the Notch signaling inhibitor Numb and mediates its ubiquitination and proteasomal degradation, thereby activating the Notch1 signaling pathway and upregulating its downstream genes. In addition, analysis of the TCGA dataset revealed that elevated RNF126 expression is a significant prognostic factor associated with increased mortality risk in ovarian cancer.Conclusions:These findings establish RNF126 as a critical contributor to cisplatin resistance in ovarian cancer via regulation of the Numb/Notch1 pathway and highlight its potential as a therapeutic target to counteract chemoresistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, The First Affiliated Hospital of Harbin Medical University, 150001 Harbin, Heilongjiang, China.
- Department of Gynecology, Heilongjiang Provincial Hospital, 150036 Harbin, Heilongjiang, China.
- School of Basic Medical Sciences, Harbin Medical University, 150081 Harbin, Heilongjiang, China.
Förderung
- Fund of Scientific Research Innovation of the First Affiliated Hospital of Harbin Medical University
- Project of the Health Commission of Heilongjiang Province
Zitieren
APA
Zheng, T., Wu, H., Niu, L., Wang, X., Liu, H., & Jiang, X. (2026). E3 Ubiquitin Ligase RNF126 Promotes Ovarian Cancer Progression and Cisplatin Resistance Through Targeting Numb/Notch1 Axis. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl54223
Vancouver
Zheng T, Wu H, Niu L, Wang X, Liu H, Jiang X. E3 Ubiquitin Ligase RNF126 Promotes Ovarian Cancer Progression and Cisplatin Resistance Through Targeting Numb/Notch1 Axis. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl54223
BibTeX
@article{Zheng2026,
author = {Zheng, Tianjiao and Wu, Han and Niu, Li and Wang, Xiaodong and Liu, Hailiang and Jiang, Xinyan},
title = {E3 Ubiquitin Ligase RNF126 Promotes Ovarian Cancer Progression and Cisplatin Resistance Through Targeting Numb/Notch1 Axis},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
doi = {10.31083/fbl54223}
}
EUVIMED